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Abstract: The nuclear phase of herpesvirus replication is regulated through the formation of
regulatory multi-component protein complexes. Viral genomic replication is followed by nuclear
capsid assembly, DNA encapsidation and nuclear egress. The latter has been studied intensely
pointing to the formation of a viral core nuclear egress complex (NEC) that recruits a multimeric
assembly of viral and cellular factors for the reorganization of the nuclear envelope. To date, the
mechanism of the association of human cytomegalovirus (HCMV) capsids with the NEC, which in
turn initiates the specific steps of nuclear capsid budding, remains undefined. Here, we provide
electron microscopy-based data demonstrating the association of both nuclear capsids and NEC
proteins at nuclear lamina budding sites. Specifically, immunogold labelling of the core NEC
constituent pUL53 and NEC-associated viral kinase pUL97 suggested an intranuclear NEC-capsid
interaction. Staining patterns with phospho-specific lamin A/C antibodies are compatible with
earlier postulates of targeted capsid egress at lamina-depleted areas. Important data were provided
by co-immunoprecipitation and in vitro kinase analyses using lysates from HCMV-infected cells,
nuclear fractions, or infectious virions. Data strongly suggest that nuclear capsids interact with
pUL53 and pUL97. Combined, the findings support a refined concept of HCMV nuclear trafficking
and NEC-capsid interaction.
Keywords: herpesviral nuclear egress; nuclear egress complex (NEC); viral protein kinase pUL97;
immunogold-electron microscopy; NEC-capsid interaction; human cytomegalovirus
1. Introduction
Human cytomegalovirus (HCMV, family Herpesviridae) represents a major, worldwide-distributed
human pathogen. Primary HCMV infection of the immunocompetent host frequently remains
asymptomatic but severe disease can occur upon infection of immunonaïve and immunocompromised
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individuals, such as neonates, transplant recipients and cancer or AIDS patients [1]. HCMV
pathogenicity is often directly linked with the efficiency of viral replication and both events are
substantially determined by the balance of virus-host interaction [2]. In this regard, prominent
examples of protein-protein interactions have been described including the formation of viral-cellular
multiprotein complexes [3–7].
The fine-regulated process of herpesviral nuclear egress is a primary obstacle for the transition
of nucleocapsids through the nuclear envelope and represents a rate-limiting step of viral replication
efficiency. Nuclear egress is not mediated by passage through the nuclear pore complex (NPC) due
to limitations in size (reviewed by [8–15]). Instead, a non-canonical pathway has been described
on the basis of nuclear lamina distortion, primary envelopment at the inner nuclear membrane
and a subsequent sequence of cytoplasmic steps including de-envelopment/re-envelopment and
virion maturation. Important molecular details of how nuclear capsid egress through the nuclear
envelope is achieved have been mechanistically elucidated recently for HCMV and other herpesviruses
(reviewed by [11,12,15–17]).
As an initial step, HCMV pUL50 and pUL53 form a core nuclear egress complex (NEC) by
heterodimerization at the nuclear rim, before they recruit further viral and cellular proteins. The main
constituents of the HCMV-specific multi-component NEC, as determined by protein interaction studies
particularly including proteomic analyses ([3] and references therein), are pUL97, p32/gC1qR, emerin,
protein kinase C (PKC) and additional proteins. Among these, pUL97 is of particular importance,
since its kinase activity is primarily responsible for nuclear lamina disassembly during the late phase
of HCMV replication. Earlier studies showed the NEC association of pUL97 is mostly mediated
in an indirect way through p32/gC1qR binding, thus bridging pUL97 to the pUL50-pUL53 core
NEC [18]. In addition, cellular protein kinases were found NEC-associated, in particular, PKC and
cyclin-dependent kinase 1 (CDK1), as identified by pUL50-specific co-immunoprecipitation [19,20].
Concerning the association of nuclear HCMV capsids with the NEC, however, the mechanism remained
widely undefined to date. A number of capsid proteins have been discussed as possible candidates
for mediating the contact with the NEC including major capsid protein (MCP) and smallest capsid
protein (SCP) [21–24]. In addition, a number of further candidates are conceivable, such as the capsid
portal protein, the capsid vertex-specific complex (CVSC), or other known capsid components (Table 1;
references a: [25–37]; b: [15,38–47]; c: [48–51]). So far, it remains unclear whether the core NEC proteins
themselves mediate capsid contacts or whether further proteins of the multi-component NEC may be
involved. In any case, the current state of the art strongly suggests a docking of HCMV capsids to
distinct sites of the nuclear envelope, termed as lamina-depleted areas (LDAs) [52–54]. The transition
through these sites is characterized by the capsid budding within large inner nuclear membrane (INM)
invaginations resulting in primary envelopment into the perinuclear space.
Table 1. Herpesviral nuclear capsid-associated proteins.







Capsid portal pUL6 pUL104 BBRF1
Capsid scaffolding pUL26.5 pUL80.5/pUL80a BdRF1
CVSC pUL17 pUL93 BGLF1
pUL25 pUL77 BVRF1
pUL36 nd nd
Terminase complex pUL15 pUL89 BGRF1/BDRF1
pUL28 pUL56 BALF3
pUL33 pUL51 BFRF1A
Cleavage-packaging pUL32 d pUL52 d BFLF1 d
NEC core protein pUL31 pUL53 e nd
Protein kinase nd pUL97 e nd
a References [25–37]; b references [38–47]; c references [48–51]; d capsid-association in question; e data of this study
and references [3,15]; nd, not determined.
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As LDAs appear to represent the preferred sites of HCMV nuclear capsid egress, the mode of
specific rearrangement of the nuclear lamina in a locally restricted manner has recently attracted major
interest of researchers and particularly lamina phosphorylation could be defined as an initial molecular
trigger (reviewed by [55]). The site-specific phosphorylation of lamins, primarily effected by HCMV
protein kinase pUL97, leads to a destabilization of the nuclear lamina. According to the current view, this
process is not only induced by lamin phosphorylation but also subsequent phosphorylation-dependent
regulatory events, such as proline cis/trans isomerization [56]. Very recently, we and others described the
functional and structural properties of herpesviral egress proteins, i.e., the essential and conserved core
NEC formed by pUL50 and pUL53 in the case of HCMV ([15] and references therein). A general hallmark
of herpesviral core NECs is their specific recruitment of further NEC-associated proteins, which in part
are identical, in other parts, however, differ between individual herpesviruses [3,5,15]. Importantly,
the herpesviral multi-component NEC has at least three different functional properties, i.e., (i) the
reorganization of the nuclear lamina through the activity of recruited effector proteins; (ii) the inner
nuclear membrane interaction to initiate viral budding processes; and (iii) the postulated docking of NEC
proteins to viral nuclear capsids (reviewed by [11,15,17]). In this report, we investigated the association
of nuclear HCMV capsids with NEC proteins and budding sites at the nuclear lamina. Specifically, we
provide evidence that the HCMV core NEC, especially its constituent pUL53, may directly associate with
virions and, moreover, that the viral nuclear protein kinase pUL97 is found associated with the core NEC.
The findings support a refined concept of the nuclear role of the HCMV-produced NEC, in particular by
facilitating the targeting of capsids to nuclear envelope budding sites.
2. Materials and Methods
2.1. Cell Culture and HCMV Infection
Primary human foreskin fibroblasts (HFFs) were cultivated in minimal essential medium
(Thermo Fisher Scientific, Waltham, MA, USA) containing 7.5% foetal calf serum, 350 µg glutamine
per mL and 100 µg gentamicin per mL. For infection experiments, HFFs (passage no. 10–15) were
plated in 6-well plates or 175 cm2 cell culture flasks at a density of 3.2 × 105 cells per well or
2–3 × 106 cells per flask, respectively. One day later, HFFs were infected with either HCMV strain
AD169 or recombinant HCMV strain AD169-GFP at multiplicities of infection (MOI) between 1.0 and
2.0 as previously described [57].
2.2. Antibodies
A description of the antibodies used in this study, i.e., for the various techniques of Western
blot (WB), immunoprecipitation (IP), in vitro kinase assay (IVKA), immunogold labelling in electron
microscopy (IEM), or further applications, is provided by Table 2 [3,6,19,20,22,24,56,58–76].
2.3. Immunogold Labelling and Transmission Electron Microscopy (TEM)
HFFs, plated on permanox coverslips (Thermo Fisher Scientific), were infected with HCMV strain
AD169 at a MOI of 2.0. At 72 h post-infection (hpi), cells were fixed with 4% paraformaldehyde
and 0.1% glutaraldehyde in 0.1 M cacodylate buffer (pH 7.4) for 10 min at room temperature. Cells
were sectioned by using an ultramicrotome (Ultracut E; Leica Microsystems, Wetzlar, Germany).
The thickness of sections to be further analysed was 30 to 40 nm. For post-embedding immunogold
labelling, fixed cells were rinsed in buffer, dehydrated serially to 70% ethanol at −20 ◦C and
embedded in LRWhite resin (Electron Microscopy Sciences, Hatfield, PA, USA). Ultrathin sections
were successively incubated in Tris-buffered saline (TBS), 0.05 M glycine in TBS, 0.5% ovalbumin and
0.5% fish gelatine in TBS, primary antibodies diluted in TBS-ovalbumin overnight at 4 ◦C and finally
in 10 nm gold-conjugated secondary antibodies (Biocell, Cardiff, UK) diluted 1:30 in TBS-ovalbumin
for 1 h. Primary antibodies included: rabbit monoclonal antibody (mAb)-Lamin A/C (EPR4100;
Abcam plc, Cambridge, UK; 1:30 dilution in PBS), rabbit polyclonal antibody (pAb)-pS22-lamin
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A/C (Cell Signaling Technology, Danvers, MA, USA; 1:5 dilution), rabbit pAb-UL97 (Boston, kindly
provided by Dr. D. Coen, Boston, MA, USA; 1:1000) and mouse pAb-UL53 (Bologna, kindly provided
by Dr. P. Dal Monte, Bologna, Italy; 1:200). After rinsing, sections were stained with uranyl acetate and
examined with a transmission electron microscope (906E, Zeiss Microscopy, Oberkochen, Germany).
For each antibody staining, the numbers of analysed sections were five to ten (each carrying approx.
50 cells) and numbers of capsid clusters were between one to five per infected cell nucleus. In negative
control experiments, the primary antibody was replaced by PBS or equimolar concentrations of
nonimmune rabbit IgG or an irrelevant primary antibody.
Table 2. Basic characteristics and specific reactivities of antibodies used in this study.
Designation Type of Antibody * Type of Antigen DemonstratedReactivity ** References
mAb-lamin A/C,




pS22 WB, IF, IEM [3,59,60]
mAb-IE1p72 (P63-27) mAb, mouse IgG purified infected cell nuclei WB, IF, IP [61–64]
pAb-UL97 (Boston) pAb, rabbit baculovirus-expressed pUL97,full-length 1-707 WB, IF, IEM, IP, MS, IV [6,65–68]
mAb-UL97 (97.01) mAb, mouse kappa IgG1 baculovirus-expressedMBP-UL97, full-length 1-707 WB, IF, IP, MS, IV, EL [6,63,69]
pAb-UL53 (Bologna) pAb, mouse bacterially expressed
β-gal-UL53, full-length 1-292 WB, IF, IEM, IP, EL [19,20,70]
mAb-UL53 (53.01) mAb, mouse kappa IgG1 bacterially expressed pUL53,fragment 50-292 WB, IF, IP, EL [3,19,20]
mAb-UL50 (50.01) mAb, mouse kappa IgG1 bacterially expressed pUL50,fragment 1-181 WB, IF, IP, EL [3,19,20]
mAb-MCP (28-4) mAb, mouse gradient-purified virions WB, IF, IP, CA, EL [22,24,71,72]




pp150/pUL32 WB, IF, IP, CA, EL [74,75]
mAb-gB (27-287) mAb, mouse bacterially expressed gp58/gB WB, IF, IP, EL [63,76]
* mAb, monoclonal antibody; pAb, polyclonal antibody; ** WB, Western blot; IF, immunofluorescence staining; IEM,
immunogold labelling in electron microscopy; IP, immunoprecipitation; MS, mass spectrometry-based proteomics
(IP with protein complexes); IV, IVKA (in vitro kinase assay/IP); CA, capsid-binding applications (IP with capsids);
EL, ELISA (enzyme-linked immunosorbent assay).
2.4. Co-immunoprecipitation (CoIP) Assay
Two 175 cm2 cell culture flasks of HCMV-infected HFFs per sample were used for protein-protein
interaction experiments utilizing CoIP. Immunoprecipitation from whole cell lysates (WCL) was
performed three days post-infection (dpi) under previously described conditions using 2 µL of mouse
mAb-UL50 (50.01) or mAb-SCP (11-2-23). In addition, CoIP experiments were performed using cell-free
virions (VIR) as input. To this end, viral particles from virus-containing supernatants of HFFs infected
with HCMV strains AD169, TB40, Merlin, or Epstein-Barr virus (EBV) strain B95-8 were pelletized
by a 3 h centrifugation step at 4 ◦C and 20,800 rcf. Subsequently, virus pellets were lysed in 500 µL
CoIP buffer (50 mM Tris/HCl (pH 8.0), 150–300 mM NaCl, 5 mM EDTA, 0.5% NP-40, 1 mM PMSF,
2 mg aprotinin mL−1, 2 mg leupeptin mL−1 and 2 mg pepstatin mL−1) and lysates were used for CoIP
as described previously [77]. In every case, CoIP samples and expression controls taken prior to the
addition of CoIP antibody (i.e. input) were subjected to standard Western blot analysis using mouse
mAbs as follows: mAb-MCP (28-4), mAb-SCP (11-2-23), mAb-UL97 (97.01), mAb-UL50 (UL50.01) and
mAb-UL53 (53.01) (produced by the authors of this study; see Table 2).
2.5. In Vitro Kinase Assay (IVKA)
Association of viral pUL97 kinase activity with nuclear HCMV capsids was determined in vitro
after cell fractionation and immunoprecipitation of HCMV capsids. Therefore, the nuclear fraction of
two 175 cm2 cell culture flasks of HCMV-infected HFFs per sample was isolated at 4 dpi using CST
Cell Fractionation Kit #9038 (Cell Signaling Technology) according to the manufacturer’s protocol.
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HCMV capsids were immunoprecipitated from the isolated nuclear fraction with 2 µL of mAb-SCP
and subjected to IVKA reaction using 5 µCi of [γ-33P] adenosine triphosphate (ATP) as described
previously [77,78]. Finally, samples were prepared for separation by 12.5% SDS-PAGE, followed
by transfer to nitrocellulose membrane (A. Hartenstein, Würzburg, Germany) for Western blotting.
Autoradiographic membranes were exposed to a phosphorimager plate and measured using a CR
35 Bio phosphorimager (raytest Isotopenmessgeräte GmbH, Straubenhardt, Germany).
3. Results
3.1. Association of HCMV Capsids with the Core NEC Constituent pUL53 Visualized by Immuno-Gold
Electron Microscopy
The nuclear egress of HCMV capsids is regulated by the multifunctional NEC. However,
the question as to how nuclear capsids are recruited to the NEC and to specific nuclear budding sites has
not been answered yet. In order to address the intranuclear fine-localization of HCMV egress proteins,
we performed immunostaining of viral proteins in ultrathin sections of infected-cell material evaluated
by electron microscopy (immuno-EM). Primary human foreskin fibroblasts (HFFs) were infected
with HCMV strain AD169 at a multiplicity of infection (MOI) of 2 and viral capsids were visualized
at budding sites of the nuclear envelope at 3 days post-infection (dpi) (Figure 1a,b). Immuno-EM
staining pointed to the association of viral pUL53, as a core NEC component, with nuclear capsids.
The signal patterns strongly suggested a tight association of pUL53 with capsids currently budding
at nuclear membranes (Figure 1a, filled arrowheads; 91% of analysed membrane-associated capsids
were coated with gold particles) and even at times prior to reaching the nuclear envelope (Figure 1a,b,
open arrowheads; 17% of intranuclear capsids were coated with gold particles). The specificity of
the used primary and secondary antibodies has been proven in control stainings of mock-infected
and HCMV-infected cells, respectively (Figure S1). This finding of pUL53-capsid interaction was
reminiscent of a recent report on herpes simplex virus type 1 (HSV-1) capsid interaction with the
pUL53 homolog pUL31, mainly based on fluorescence microscopic analyses [79].
In accordance with the EM data, the major capsid protein (MCP) was co-immunoprecipitated with
the core NEC and the NEC-associated protein kinase pUL97 from HCMV-infected whole cell lysates
(WCL) using a pUL50-specific antibody (i.e. mAb-UL50.01; Figure 1c). These findings were further
supported by performing additional co-immunoprecipitation (CoIP) experiments. Using two different
preparations of mAb-SCP, MCP was massively detected in the co-precipitate (Figure 2, middle panels).
In addition, a minor quantity of pUL53 could also be detected (Figure 2a, upper panel). The low level
of pUL53 found in the CoIP fraction with SCP might reflect the fact that only viral capsids budding
at nuclear membranes showed a constant pUL53 association in the immunogold labelling electron
microscopy (EM) analysis. It should, however, be noted as an important indication that pUL53 might
be the first contact point for nuclear capsids when they approach the viral NEC.
3.2. HCMV Kinase pUL97 Associates with Viral Capsids Already in the nucleus of Infected Cells
The possibility that capsid association of pUL53 may also include pUL97 (Figure 1c), which
is a multifunctional regulator that phosphorylates a number of substrates including pUL50 and
pUL53 [20], prompted us to address further questions about the functional consequences of these
protein interactions. To this end, we asked whether the protein kinase pUL97, particularly responsible
for the major regulatory events in nuclear lamina rearrangement during viral egress, is likewise
detectable by EM-based localization studies as a protein associated with nuclear capsids. In fact,
a staining pattern of nuclear capsid co-localization was observed for pUL97 similar to pUL53 (although
at some lower detectable quantity than pUL53, i.e., approx. 33% of evaluated capsids were found
pUL97-associated; Figure 3a). The signal distribution suggests an interaction of pUL97 with the surface
interface of variable stages of nuclear particles (Figure 3b,c). The specificity of the antibody staining
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was again analysed using mock-infected and HCMV-infected cells (Figure S2). Notably, the control
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Figure  1.  Association  of  the  viral  core  nuclear  egress  complex  (NEC)  constituent  pUL53  with 
intranuclear  human  cytomegalovirus  (HCMV)  capsids  and  capsids  budding  at  the  inner  nuclear 
membrane (INM). (a,b) HCMV‐infected primary human foreskin fibroblasts (HFFs) were harvested 
at  3  dpi  and  subjected  to  immunogold  staining  of  viral  pUL53.  Samples  were  analysed  by 
transmission  electron microscopy  (TEM),  35,970‐fold magnification. NE,  nuclear  envelope;  open 
arrowheads,  intranuclear HCMV  capsids;  filled  arrowheads, HCMV  capsids  budding  at  nuclear 
membranes;  (c) Co‐immunoprecipitation  (CoIP)  analysis with HCMV‐infected whole  cell  lysates 
(WCL). HCMV‐ or uninfected  (mock)‐HFFs were  lysed at 4 dpi  followed by  immunoprecipitation 
with monoclonal antibody (mAb)‐UL50.01 coupled to protein A sepharose (lanes 3–4) or empty beads 




Figure 1. Association of the viral core nuclear egress complex (NEC) constituent pUL53 with
intranuclear human cytomegalovirus (HCMV) capsids and capsids budding at the inner nuclear
membrane (INM). (a,b) HCMV-infected primary human foreskin fibroblasts (HFFs) were harvested at
3 dpi and subjected to immunogold staining of viral pUL53. Samples were analysed by transmission
electron microscopy (TEM), 35,970-fold magnification. NE, nuclear envelope; open arrowheads,
intranuclear HCMV capsids; filled arrowheads, HCMV capsids budding at nuclear membranes;
(c) Co-immunoprecipitation (CoIP) analysis with HCMV-infected whole cell lysates (WCL). HCMV-
o uninfe ted (mock)-HFFs were lysed at 4 dpi followed by immunoprecipitation with monoclonal
antibody (mAb)-UL50.01 coupled to protein A s pharos (lanes 3–4) or empty beads as a CoIP negative
control (lanes 1–2). CoIP samples (lanes 1–4) and expression control samples (input, representing
one-twentieth of CoIP samples; lanes 5–6) were subjected to Western blot analysis using protein-specific
antibodies. Ig-HC, cross-reactive band for immunoglobulin heavy chain; MCP, major capsid protein.






(GFP)  or  remained  uninfected  (mock)  as  indicated.  Cells  were  lysed  at  4  dpi  followed  by 
immunoprecipitation with  a monoclonal  antibody  (mAb)  against  SCP  produced  as  a  protein A 

























In  order  to  substantiate  the  potential  interaction  between  pUL97  and HCMV  capsids, we 
investigated  if  nucleocapsid‐associated  pUL97  exerts  kinase  activity.  For  this  purpose,  nuclear 
extracts were prepared  from HCMV‐infected  fibroblasts  and pUL97 was  co‐immunoprecipitated 
with nuclear HCMV capsids by the use of mAb‐SCP. An assessment of pUL97 autophosphorylation 
Figure 2. Interaction of HCMV capsid proteins SCP and MCP with the core NEC constituent
pUL53. HFFs were infected with recombinant HCMV strain AD169 expressing the green fluorescent
protein (GFP) or remained uninfected (mock) as indicated. Cells were lysed at 4 dpi followed by
immunoprecipitation with a monoclonal antibody (mAb) against SCP produced as a protein A purified
tissue culture supernatant (mAb-SCP PrtA; lanes 1–2) or ascites fluid (mAb-SCP Ascites; lanes 3–4).
Co-immunoprecipitates (a) and expression control samples (input; (b)) were subjected to Western blot
analysis using protein-specific antibodies. SCP, smallest capsid protein; MCP, major capsid protein;
Ig-HC and Ig-LC, cross-reactive band for immunoglobulin heavy and light chains.
Next, we confirmed the EM-based evidence of pUL97-capsid interaction by performing CoIP
using protein lysates from virion stocks of the HCMV strains AD169, TB40 and Merlin. In this setting,
mAb-SCP was able to co-immunoprecipitate both MCP and pUL97 (Figure 3d,e). For pUL97, the most
prominent signals of interaction were obtained for strain AD169 (Figure 3e, lanes 1–2), which may
relate to the high titre of this viral stock. It should be mentioned that SCP is highly conserved among
the three strains, i.e., >95% identity on amino acid level (with a single amino acid exchange of SCP
Merlin at position V68I). Interestingly, SCP—detectable with a molecular weight of approx. 12 kDa in
control lysates (see Figure 2, lanes 2 and 4)—migrated at a high molecular size of≥130 kDa, even larger
than MCP, in the input and immunoprecipitates from virion lysates (Figure 3d, lanes 1–2 and Figure 3e,
lanes 1–3). One possible explanation would be a tightly linked packaging of SCP together with MCP
in virions, which is not separable by standard denaturating SDS-PAGE. We confirmed the detectability
of this high molecular form of SCP when we used whole cell lysates of HCMV-infected cells for CoIP
with monoclonal antibodies against three different structural proteins, i.e., mAb-MCP, mAb-pp150 and
mAb-gB. Note that recent structural investigations proved the tight association of pp150 with capsids,
particularly a pp150 cysteine tetrad–to-SCP interaction [23] (which might possibly not be completely
resolved by SDS-PAGE). In our supplemental experiment, all three mAbs proved to be active in CoIP
under these conditions and produced co-immunoprecipitates between MCP, pp150 and SCP (while gB
appeared to be mostly separated by the use of detergents in the CoIP lysis buffer). Specifically, for SCP
two forms were detected, namely the small 12-kDa SCP and an inseparable high molecular weight
form ≥130 kDa, which might represent a covalent conjugate either with pp150 or a so far undefined
other protein (Figure S3).
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arrowheads,  intranuclear HCMV  capsids;  filled  arrowheads, HCMV  capsids  budding  at  nuclear 
membranes;  (d,e) CoIP analysis with  cell‐free virions  (VIR) as  input. Virions  from HCMV  strains 
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Figure 3. Associati n of the HCMV-encoded protein kinase pUL97 with vir l caps ds in the nucleus.
(a–c) HCMV-inf cted HFFs were harv sted at 3 dpi and subj cted to immunogold staining of viral
pUL97. Samples were analysed by TEM, 35,970-fold magnification. NE, nuclear envelope; open
arrowheads, intranuclear HCMV cap ids; filled arrowheads, HCMV cap ids budding at nuclear
embranes; (d,e) CoIP analysis with cell-free virions (VIR) as input. Virions from HCMV strains
AD169, TB40 or Merlin (harvested from dentic l quantities of HFF producer cell layers, i.e., one
T175 flask ach) were lysed followed by CoIP using protein A-purified mAb-SCP (PrtA) or unpurified
superna ant of mAb-SCP hybridoma c ltures (SN). EBV strain B95-8 or buff r s rved as CoIP negative
controls ((d) lanes 4–5; (e) lanes 7–10). CoIP sampl s (e) and expression control samples (input; (d))
were both subj cted to W stern blot analysi using antibodies against the indicated proteins. Note,
no band was det cted at the molecular weight of approximately 72 kDa using antibo y dir cted
against immediate early protein (IE1p72; (e), lower panel) pointing to the specificity of the CoIP.
Ig-HC, cross-reactive band for immunoglobulin heavy chain.
In order to substantiate the potential interaction between pUL97 and HCMV capsids, we
investigated if nucleocapsid-associated pUL97 exerts kinase activity. For this purpose, nuclear extracts
were prepared from HCMV-infected fibroblasts and pUL97 was co-immunoprecipitated with nuclear
HCMV capsids by the use of mAb-SCP. An assessment of pUL97 autophosphorylation activity was
performed by in vitro kinase assays (IVKA). The results indicated capsid-associated activity of pUL97
(Figure 4a, lane 1; see pUL97 autophosphorylation, lower panel). The three previously characterized
isoforms of pUL97, all known to possess autophosphorylation activity [67], were labelled to illustrate
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the specificity of the bands. The autoradiography shows a reduction of pUL97 autophosphorylation
















used  for  immunoprecipitation  of HCMV‐encoded  proteins  SCP,  pUL97,  or  IE1p72  as  a  control. 
Precipitates were subjected subsequently to a pUL97‐specific in vitro kinase assay (IVKA). (a), upper 
panels CoIP) Prior  to  IVKA  reactions,  the quality of CoIP  samples was verified by Western blot 
analysis.  (a),  lower  panel  Autoradiography)  IVKA  reactions  were  performed  under  conditions 
optimized for pUL97 activity and signals of autophosphorylation are depicted. Note the labelling of 
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LDAs  [52,54]. The  typical pattern of  lamin redistribution  in HCMV‐infected cells  includes  lamina 
Figure 4. The kinase activity of capsid-associated p L97 purified from the nucleus of HCMV-infected
cells. HFFs were infected with recombinant HCMV AD169-GFP and treated with the pUL97 kinase
inhibitor maribavir (MBV) or the solvent dimethylsulfoxide (DMSO). At 4 dpi, cells were harvested and
the nuclear fraction (NUC) was isolated from whole cell lysates (WCL). The nuclear fraction was used
for immunoprecipitation of HCMV-encoded proteins SCP, pUL97, or IE1p72 as a control. Precipitates
were subjected subsequently to a pUL97-specific in vitro kinase assay (IVKA). ((a), upper panels CoIP)
Prior to IVKA reactions, the quality of CoIP samples was verified by Western blot analysis.
((a), lower panel Autoradiography) IVKA reactions were performed under conditions optimized
for pUL97 activity and signals of autophosphorylation are depicted. Note the labelling of the three
known soforms of pUL97, M1, M74 and M157, which all possess autophosphorylation activity; (b) The
input levels of all relevant proteins were stained on parallel Western blot panels.
Maximal act vity of pUL97 was monitored by use of mAb-UL97 (Figure 4a, lanes 3–4) and
the s ecificity of the reaction was controlled by mAb-IE1, not showing any background signal of
pUL97 activity (Figure 4a, lane 5; for expression levels of viral proteins and the success of nuclear
extraction, i.e., separation of nuclear lamins A/C from cytoplasmic aldolase, are shown in Figure 4b).
This result argues for very early binding of catalytically active pUL97 to nuclear stages of viral capsids
that may be required for subsequent steps of nuclear egress regulation. Note that this IVKA result
may provide a first argument for pUL97-capsid interaction, either through direct or indirect contact
possibly involving further NEC proteins.
3.3. Targeted Mode of Lamina Disassembly by Capsid-Associated pUL97
To visualize virus-induced phosphorylation of the nuclear lamina, which is mainly
mediated by pUL97 kinase activity [4,18,52,56,80,81], monoclonal or polycolonal antibodies
(mAb/pAb) against nuclear lamin A/C were used for immuno-EM, either recognizing lamins in
a phosphorylation-independent or phosphorylation-dependent manner (Figure 5, Figure 6 and Figure
S4). As previous reports demonstrated a major site of lamin phosphorylation at position serine 22,
pAb-pS22-lamin A/C was applied in this analysis (Figure 6c–e) and was compared to signals obtained
for overall lamin A/C detection with mAb-lamin A/C (Figures 5 and 6a,b). The homogeneous rim-like
distribution of lamin A/C signals observed in uninfected cells (Mock, Figure 5a and Figure S4b) was
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drastically altered in HCMV-infected cells; i.e., a thinning of lamin A/C-specific immuno-EM grains
was detected (Figure 5b and Figure S4a), which corresponds to the earlier description of nuclear
lamina thinning and the induction of LDAs [52,54]. The typical pattern of lamin redistribution in
HCMV-infected cells includes lamina thinning and the formation of lamina-depleted areas. However,
it was surprising to detect that despite of the low concentration of lamina-associated gold particles
at the nuclear envelope of HCMV-infected cells, budding events were exclusively found at sites
which were still decorated with lamin A/C , (Figures 5b and 6a, filled arrowheads). In fact, staining
with pAb-pS22-lamin A/C suggested that this portion of lamin A/C is still phosphorylated at
serine 22 (Figure 6c and Figure S4e) which is a prerequisite for lamin dissociation from the nuclear
envelope. Interestingly, a similar association of lamins, stained with either mAb-lamin A/C or the
phospho-specific pAb-pS22-lamin A/C, was observed with capsids adjacent to intranuclear membranes
(Figure 6b,d). These structures resemble previously described large tubular INM infoldings which
were postulated to be utilized for nuclear egress of human and mouse cytomegalovirus (MCMV)
capsids [53]. Taken together, it is intriguing to speculate that nuclear capsids not only interact with the
viral core NEC and pUL97 but also with nuclear lamins, which undergo site-specific phosphorylation
during the process of nuclear egress in a capsid/NEC-associated manner.
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4. Discussion
A series of recent reports addressed questions about the regulation of HCMV nuclear egress
orchestrated by the HCMV-specific core NEC forming a multi-component viral-cellular NEC extension
reviewed by [15]. However, the association of the NEC with HCMV nuclear capsids remained
enigmatic in several aspects. Our study focused on experimental approaches illustrating the association
of viral capsids with the HCMV-specific core NEC and viral protein kinase pUL97 (Figure 7).
The central findings were as follows: (i) nuclear HCMV capsids may directly associate with NEC
proteins at viral budding sites of the nuclear lamina; (ii) the core NEC constituent pUL53 and
viral protein kinase pUL97 showed, at least to some extent, intranuclear interaction with virions;
(iii) in vitro kinase assays provided initial evidence for kinase activity of capsid-associated pUL97;
and (iv) immune-EM staining patterns using phospho-specific and phospho-independent lamin
A/C antibodies are compatible with our earlier postulate of a targeted mode of virion egress at
lamina-depleted areas.
Data presented in this study on the association of pUL53 with intranuclear HCMV capsids appear
to be congruent with previous reports using HSV-1 and pseudorabies virus (PRV), in which it was
demonstrated that the core NEC of these two alpha-herpesviruses binds to viral capsids [82–84].
In particular, the PRV and HSV-1 pUL31 proteins, homologs of HCMV pUL53, were identified to
be enriched on purified viral particles and pUL31-capsid binding was shown to be independent of
its core NEC partner pUL34 [82,83]. Consistent with this, we observed HCMV pUL53 associated
with viral capsids in the nucleus of infected cells by EM immunogold staining. Interestingly,
this was not restricted to capsids located at the nuclear envelope, presumably budding into the
perinuclear space but pUL53 coating was also observed on capsids which had not yet reached the
INM. Co-immunoprecipitation analyses confirmed that pUL53, as well as its core NEC partner pUL50,
is strongly suggested to be bound to the structural capsid proteins MCP and SCP. In a previous
study, we identified MCP and the HCMV triplex protein pUL85 associated with pUL50-pUL53 when
analysing complexes from HCMV-infected cells by mass spectrometry [3]. As all these proteins,
MCP, SCP and pUL85, represent structural components, they may provide a direct link between
nuclear viral particles and the core NEC. In previous studies, we and others showed that pUL50 is
targeted to the INM, probably exclusively due to the function of its transmembrane domain [78,85–87].
The immunogold-EM data presented in this study suggests that capsid binding may be mediated by
the pUL53 component of the core NEC. In line with this, based on the crystal structures of the core
NECs of HCMV, HSV-1 and PrV [88–91], a conserved alpha-helix in pUL53 at the membrane-distal
end of the NEC was proposed to mediate binding to the capsid [11,14].
To this end, it remains to be elucidated whether an additional viral or cellular capsid-associated
protein may support this interaction. Notably, candidate proteins for the recognition of capsids by
the core NEC were recently proposed for HSV-1 [83,84]. The HSV-1 homolog of pUL53 binds to
a complex of the HSV-1-encoded proteins pUL17 and pUL25 [83]. These proteins, together with a third
HSV-1 protein, i.e., pUL36, belong to a heterotrimeric complex located exclusively at the vertices of the
icosahedral herpesviral capsid, which is therefore termed capsid vertex-specific complex (CVSC) [25].
Due to preferential loading of the CVSC on DNA-containing capsids (termed C capsids), binding of
the core NEC to the CVSC might provide the mechanistic basis of a quality control to assure nuclear
egress of only mature C capsids. The general importance of the CVSC for HSV-1 nuclear egress was
at least shown for pUL25 [92]. In the absence of pUL25, neither primary enveloped particles in the
perinuclear space nor capsids in the cytoplasm were observed by transmission electron microscopy
(TEM), although all capsid types, including C capsids, were regularly formed and even were detected
frequently adjacent to the INM [92]. In the case of HCMV, there is conflicting evidence as to whether the
homologous CVSC proteins, pUL77 and pUL93, can interact with one of the core NEC proteins [93,94].
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The presented data furthermore suggests that at least a portion of pUL53, which is not yet
incorporated into the NEC located at the INM, associates with HCMV capsids somewhere in the
nucleoplasm. It is tempting to speculate that pUL53-coated capsids might subsequently reach the INM
to dock to membrane-bound pUL50. This is consistent with the recently revealed mechanism of capsid
transport to the INM based on free diffusion through chromatin-devoid areas (i.e. interchromatin
corrals) enlarged in herpesvirus-infected cells (Figure 7b) [95,96]. It is worthy of note that final capsid
docking at the INM might require hexameric assemblies of the core NEC as postulated recently [15].
In particular, according to the recent crystal structures, the HCMV core NEC forms hexameric ring-like
arrangements [88]. The stoichiometry and size of these rings matches that of the hexon-ordered
arrangements of the major capsid protein. For this reason, it seems plausible that both hexameric
structures, i.e., NEC and capsids, may directly interact with each other during nuclear egress [15].
However, such an interaction would also imply that the monomeric building blocks of these structures,
e.g., pUL53 and an individual capsid protein, may additionally be capable to interact with each other,
although with much lower affinity.
This point was strongly illustrated by our theoretical estimate, which generally suggests
an increase of affinity resulting from multivalent interactions compared to monomeric interactions.
We speculated whether monomeric pUL53 interaction with capsids might occur at a lower affinity
than multivalent interaction of the hexameric pUL50-pUL53 NEC with capsids. For this purpose,
an inspection of the literature was compiled in Table 3 references [97–107]. Most of the examples refer
to protein-ligand interactions that gain affinity upon multimerization. For example, the Sos1 protein
contains five proline-rich motifs that interact with the two SH3 domains of Grb2. The effective
dissociation constant (Kd) for the formation of a Sos1-Grb2 complex is 100 times smaller than the
smallest Kd for the binding of a single Grb2 SH3 domain to a proline-rich motif on Sos1 [99]. In addition,
there are also several examples demonstrating that this principle similarly applies to the interaction
of proteins with lipids, sugars, or DNA (Table 3). For example, the multimeric protein S binds with
at least 250-fold higher affinity to phospholipid bilayers compared to monomeric protein S [97].
For the methyl-CpG-binding domain (MBD) protein, which recognizes methylated CpG sites in
double-stranded DNA, a covalently linked tetramer binds DNA more than 50 fold tighter than
a monomeric MBD [98]. The gain in affinity for the multimeric interactions ranges from one to five
orders of magnitude depending on the nature and stoichiometry of the interaction. The highest
gain in affinity (>104 fold) is observed for a pentameric compared to a monomeric ligand binding to
the pentameric heat-labile enterotoxin (Table 3). From all systems referenced, the stoichiometry is
closest to that of a putative hexamer-hexamer interaction between HCMV core NEC and capsid. Thus,
we propose that a hexameric compared to a monomeric kind of NEC-capsid interaction would cause
a rather large gain in affinity that might even exceed the values reported in Table 3.
Moreover, immunogold-EM confirmed previous studies based on confocal microscopy, which
stated that local disassembly of the nuclear lamina was induced in HCMV-infected cells [4,18,52,80].
However, it was surprising to see that the remaining lamin A/C was enriched at capsid budding sites
of the nuclear envelope. The use of a phospho-dependent antibody indicated that these lamin A/C
molecules are already phosphorylated at serine 22 and, therefore, are likely to be dissociated from
the residual nuclear lamina [56,108]. Consistent with this, we hypothesized that the HCMV protein
kinase pUL97 may also bind to capsids in the nucleus (Figure 7a). It is known that pUL97, being
a component of the herpesvirus-characteristic tegument layer, is packaged into HCMV particles, which
are released from the host cell [109,110]. However, to date, it is not clear whether a substantial quantity
of pUL97 already associates with HCMV capsids in the nucleus or in a later step during maturation
in the cytoplasm. Thus, it remains to be elucidated whether pUL97 is permanently associated with
capsids during nuclear egress and cytoplasmic maturation or whether nuclear capsid-binding of
pUL97 is transient and final tegumentation of pUL97 takes place at a later stage in the cytoplasm.
Viruses 2018, 10, 35 15 of 21
Table 3. Published examples of increased affinities resulting from multivalent types of
protein-ligand interaction.
First Binding Partner Second Binding Partner Type of Complex Formed Gain in Affinity References
S protein Phospholipid bilayer Multimeric protein S >250 fold [97]
MBD protein DNA CpG sites Tetrameric MBD >50 fold [98]
Grb SH3 domain Proline-rich motif of SOS Two SH3 domains and fiveproline-rich motifs >100 fold [99]
ZAP70 SH2 domain ITAM motifs of Syk kinase Two SH2 domains and twoITAM motifs >100 fold [100]
HPV E6 protein Peptidic ligand Bivalent peptidic ligand >300 fold [101]
Lectins Sugar ligands Multimeric lectins and ligands 1–3 orders ofmagnitude [102]
Staphylococcal
protein A Affibody Dimeric affibody
3 orders of
magnitude [103]
Monoclonal IgG I Fcγ receptors RIIAand RIIIB Dimeric IgG I 200–800 fold [104]
Receptor tyrosine
kinase VEGFR-2 Peptidic ligand Dimeric peptidic ligand 6–500 fold [105]
E. coli heat-labile
enterotoxin (pentamer) Galactose (monomer)
Five galactose moieties linked
by a pentavalent scaffold >10
4 fold [106,107]
5. Conclusions
In conclusion, we provide novel insights into the specific mechanisms and protein interactions
relevant to HCMV nuclear egress. In particular, data are consistent with the idea that the core NEC
constituent pUL53 may be involved in the transport of newly assembled HCMV capsids from the
nucleoplasm to the nuclear envelope (Figure 7a). It remains to be determined whether this process
really involves an active recruitment of capsids along nuclear filaments such as F-actin that, in addition,
may essentially be dependent on pUL53. Alternatively, it seems suggestive that nuclear envelope
targeting of capsids may be mediated by crossing interchromatin corrals by Brownian motion in the
end connected with the capsids’ pUL53-pUL50 core NEC interaction. In both cases, current data
suggests that budding into the perinuclear space can either occur at the nuclear envelope or even at
large INM infoldings (Figure 7b). Future studies will have to provide more molecular data to confirm
this concept and to clarify further details of the process.
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